Amha Atakilit Patents – Key Insights and Stats

Amha Atakilit is a specialist at the University of California and has 46 patents filed globally that belong to 8 patent families. Dean Sheppard, Professor, UCSF School of Medicine, is co-inventor in all of his patent applications which are assigned to the University of California, Pfizer, and Biogen.

Amha Atakilit inventions are focused on the roles of αvβ5 and αvβ8 integrin in models of common lung disease, and different methods and composition for treating and preventing disease associated with αvβ5 integrin. The table at the bottom provides further information on Amha Atakilit’s patents.

Assignees’ of Amha Atakilit Patents

All of Amha Atakilit’s patents are assigned to the University of California among which two patents are jointly owned by Pfizer, and one by Biogen.

Amha Atakilit Patents

Worldwide Coverage of Amha Atakilit Patents

Amha Atakilit Patent Filing Worldwide

Application Area of Amha Atakilit Patents

Pub NumberFiling YearAssigneeTitleApplication Area
US10597455B22018University Of CaliforniaMethods and compositions for treating and preventing disease associated with αvβ5 integrinIn the treatment of tissue fibrosis, acute lung injury and pulmonary emphysema
CA2767409C2010University of CaliforniaMethods and compositions for treating and preventing disease associated with αvβ5 integrinTreatment of Sepsis
US10005838B22016University of CaliforniaMilk fat globule epidermal growth factor 8 regulates fatty acid uptakeTreatment of Diabetes by increasing insulin sensitivity
ES2671522T32005University of CaliforniaMethods and compositions for treating and preventing a disease associated with integrin αvβ5Treatment or prevention of pulmonary edema and acute lung injury
AU2012216372B22012University of CaliforniaMethods and compositions for treating and preventing disease associated with αvβ5 integrinTreatment of acute lung injury
TW202024131A2019Pfizer, and University of CaliforniaAnti-αvβ8 antibodies and compositions and uses thereof
WO2020051333A82019Pfizer, and  University Of CaliforniaAnti-αvβ8 antibodies and compositions and uses thereof
WO2014144616A32014Biogen Inc., and University Of CaliforniaAnti-αvβ5 antibodies and uses thereofTreatment of acute lung injury, (ARDS), PE, lung fibrosis, sepsis, stroke, , cancer, and ocular neovascularization disease

Related Articles

Shunpei Yamazaki Patents – Insights and Stats (Updated 2024)

Shunpei Yamazaki is a pioneering Japanese inventor who created the basic device for flash memory while studying at Doshisha University in 1970. His ground-breaking work in non-volatile memory technology laid the foundation for many modern electronics. After earning his Ph.D. in Engineering, Yamazaki founded Semiconductor Energy Laboratory in 1980, where

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.